Lyka Labs - Quaterly Results

26 May 2025 Evaluate
The Revenue for the quarter ended  March 2025 of Rs. 305.17 millions grew by 13.09 % from Rs. 269.84 millions.The Total Profit for the quarter ended March 2025 of Rs. 13.07 millions grew from Rs.-16.22 millionsOperating profit for the quarter ended March 2025 rose to 41.30 millions as compared to 26.05 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 305.17 269.84 13.09 1346.97 1063.96 26.60 1346.97 1063.96 26.60
Other Income 7.20 3.90 84.62 23.44 16.47 42.32 23.44 16.47 42.32
PBIDT 41.30 26.05 58.54 202.32 162.07 24.83 202.32 162.07 24.83
Interest 5.20 10.35 -49.76 23.04 47.98 -51.98 23.04 47.98 -51.98
PBDT 36.10 15.60 131.41 179.28 113.54 57.90 179.28 113.54 57.90
Depreciation 13.38 27.72 -51.73 64.53 122.87 -47.48 64.53 122.87 -47.48
PBT 22.72 -12.12 -287.46 114.75 -9.33 -1329.90 114.75 -9.33 -1329.90
TAX 9.65 4.10 135.37 32.47 13.37 142.86 32.47 13.37 142.86
Deferred Tax 3.45 0.55 527.27 5.23 -2.63 -298.86 5.23 -2.63 -298.86
PAT 13.07 -16.22 -180.58 82.28 -22.70 -462.47 82.28 -22.70 -462.47
Equity 356.90 330.90 7.86 356.90 330.90 7.86 356.90 330.90 7.86
PBIDTM(%) 13.53 9.65 40.19 15.02 15.23 -1.39 15.02 15.23 -1.39

Lyka Labs Share Price

78.32 -2.72 (-3.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×